Showing 1 - 6 results of 6 for search 'Anne‐Laure Giraudet', query time: 0.04s
Refine Results
-
1
A review of 177Lu dosimetry workflows: how to reduce the imaging workloads? by Laure Vergnaud, Yuni K. Dewaraja, Anne-Laure Giraudet, Jean-Noël Badel, David Sarrut
Published 2024-07-01
Article -
2
Patient-specific dosimetry adapted to variable number of SPECT/CT time-points per cycle for $$^{177}$$ 177 Lu-DOTATATE therapy by Laure Vergnaud, Anne-Laure Giraudet, Aurélie Moreau, Julien Salvadori, Alessio Imperiale, Thomas Baudier, Jean-Noël Badel, David Sarrut
Published 2022-05-01
Article -
3
-
4
A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR) by David Kryza, Armelle Vinceneux, Anne-Sophie Bidaux, Gwenaelle Garin, Delphine Tatu, Claire Cropet, Jean-Noël Badel, David Perol, Anne-Laure Giraudet
Published 2024-02-01
Article -
5
Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma by Anne Laure Giraudet, Armelle Vinceneux, Valentin Pretet, Emilie Paquet, Alicia Sanchez Lajusticia, Fouzi Khayi, Jean Noël Badel, Helen Boyle, Aude Flechon, David Kryza
Published 2023-07-01
Article -
6
From netrin‐1‐targeted SPECT/CT to internal radiotherapy for management of advanced solid tumors by David Kryza, Jennifer Wischhusen, Mathieu Richaud, Maëva Hervieu, Jacqueline Sidi Boumedine, Jean‐Guy Delcros, Sophie Besse, Thomas Baudier, Pierre‐Alexandre Laval, Silvia Breusa, Erwan Boutault, Hugo Clermidy, Nicolas Rama, Benjamin Ducarouge, Mojgan Devouassoux‐Shisheboran, Jean‐Michel Chezal, Anne‐Laure Giraudet, Thomas Walter, Patrick Mehlen, David Sarrut, Benjamin Gibert
Published 2023-03-01
Article